Glucon Continuous Glucose Watch uses Photoacoustics to map the influence of the glucose on the optical properties of the blood inside blood vessels. The company’s desktop prototype device, is currently undergoing extensive clinical trials. Suzuken Co., Ltd, Japan’s largest pharmaceuticals distributor, invested $14.8 million in Glucon to acquire exclusive rights …
Read More »Diabetes In Control
Utility of Hemoglobin A1c in Predicting Diabetes Risk, Underused
HbA1c testing helps predict the likelihood that patients will develop diabetes in the future.
Read More »Teens With Diabetes Face Future Bone Frailty
Despite normal growth and maturation, young people with type 1 diabetes appear to lag in bone development.
Read More »Twice-Daily Insulin Yields Suboptimal Metabolic Control in Diabetic Preschoolers
In preschool children with type 1 diabetes, twice-daily insulin injections fail to provide adequate glycemic control, with frequent and prolonged episodes of either hypo- or hyperglycemia.
Read More »Peptide Replacement Prevents Painful Diabetic Neuropathy
Findings from a new study suggest that C-peptide replacement may be a useful treatment for painful diabetic neuropathy that occurs under insulin-deficient conditions.
Read More »Pharmacy Claims Data Useful Gauge of Diabetic Drug Adherence
Adherence to medication, measured by prescription drug claims data, is associated with intermediate clinical outcomes and may therefore be useful in clinical practice.
Read More »New Drug Protects Against the Hardening of Arteries
PPARs in atherosclerosis: the clot thickens
Read More »Exercise Prevents Mental Decline In Older Men
European study indicates that it’s never too late to get benefit from physical activity,
Read More »Smoking During Pregnancy Tied to Gestational Diabetes Risk
Mean plasma glucose concentrations increased by 0.5 mg/dL for each cigarette smoked per day.
Read More »Mortality Increased For Diabetics With Heart Failure Using Insulin
Patients with advanced heart failure (HF) and insulin-treated diabetes have about a fourfold greater risk of dying compared with non-diabetic HF and non-insulin treated diabetic HF patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.